CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled platform for mapping the therapeutic potential of stem cell secreted proteins and engineering restorative biologics for age-related and chronic diseases on the podcast Impact AI
One of In Vivo’s 2024 Rising Leaders, Dr. Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company’s lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.
Discovery of Biologic Therapeutics in the AI/ML Era: 20-year industry veteran and Vice President of Data Science, Dr. Edward Moler, PhD, shares his insights on navigating AI-driven discoveries with high therapeutic potential
Check out the Pharma Exec Podcast of CEO Dr. Hanadie Yousef’s interview for the Emerging Pharma Leader award to learn more about what drives her ambitions for Juvena
Juvena’s Head of Data Science, Dr. Eddie Moler interviewed about his experiences in data science and AI applied to diagnostics and drug discovery and shares why he is excited about Juvena